Literature DB >> 11718594

A fatal case of Vibrio vulnificus presenting as septic arthritis.

R W Johnson1, F C Arnett.   

Abstract

Vibrio vulnificus is an invasive gram-negative bacillus that may cause necrotizing cellulitis, bacteremia, and/or sepsis. Although V vulnificus infection is uncommon, it is frequently fatal and is usually attributed to ingestion of raw shellfish or traumatic exposure to a marine environment; patients are also often found to have a hepatic disorder (cirrhosis, alcohol abuse, or hemochromatosis) or an immunocompromised health status, and most commonly present with septicemia or a wound infection. We describe a patient who presented with septic arthritis as the first clinical manifestation of a V vulnificus infection. The organism was subsequently identified in a synovial fluid aspirate.

Entities:  

Mesh:

Year:  2001        PMID: 11718594     DOI: 10.1001/archinte.161.21.2616

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

Review 1.  Hepcidin: the missing link between hemochromatosis and infections.

Authors:  Houman Ashrafian
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Sepsis with bullous necrotizing skin lesions due to vibrio vulnificus acquired through recreational activities in the Baltic Sea.

Authors:  K Kuhnt-Lenz; S Krengel; S Fetscher; A Heer-Sonderhoff; W Solbach
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-04       Impact factor: 3.267

3.  Septic arthritis and subsequent fatal septic shock caused by Vibrio vulnificus infection.

Authors:  Amir Emamifar; Rikke Asmussen Andreasen; Nanna Skaarup Andersen; Inger Marie Jensen Hansen
Journal:  BMJ Case Rep       Date:  2015-11-24

Review 4.  Vibrio vulnificus: An Environmental and Clinical Burden.

Authors:  Sing-Peng Heng; Vengadesh Letchumanan; Chuan-Yan Deng; Nurul-Syakima Ab Mutalib; Tahir M Khan; Lay-Hong Chuah; Kok-Gan Chan; Bey-Hing Goh; Priyia Pusparajah; Learn-Han Lee
Journal:  Front Microbiol       Date:  2017-05-31       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.